^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
AmoyDx® FGFR2 Break-apart FISH Probe Kit

Type:
Other Approval
Related tests:
Evidence

News

4ms
AmoyDx® FGFR2 Break-apart FISH Probe Kit approved as companion diagnostic for Eisai’s Tasurgratinib in Japan (AmoyDx Press Release)
"Amoy Diagnostics Co., Ltd...announces that its AmoyDx® FGFR2 Break-apart FISH Probe Kit has been approved as a companion diagnostic (CDx) for Eisai’s innovative targeted therapy, Tasurgratinib in Japan. This approval marks a significant milestone in precision oncology, enhancing the treatment options for biliary tract cancer patients with FGFR2 gene fusions."
Japan approval
|
AmoyDx® FGFR2 Break-apart FISH Probe Kit